TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Stability of the capillary blood sample after storage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Comprehensive Breast Cancer Follow-up Care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Qualitative themes on healthy living and behavioral interventions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Qualitative themes on perceptions and attitudes toward intervention protocols
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Qualitative themes on feedback of web-based interface
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neurological death or disabling stroke
Endpoint domain: Mortality/survival
Primary endpoint: Percent of Patients Reporting Medication Optimization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first documented recurrence of AF/AFl/AT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oswestry Disability Index (ODI) for disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SHORT FORM-36 for HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average BP change comparing CardioWatch 287-2 and reference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients completing medication review phone call
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tumor response according to the iRECIST criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of irAE
Endpoint domain: Adverse events/effects
Primary endpoint: FVC Lung Functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 Lung Functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1/FVC Ratio Lung Functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in crying/fussing duration
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feeling high, Numeric rating scale 0 -10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Euphoric
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients who Consent to Study Participation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Patients who Complete the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Single Ease Question (SEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number and percentage of patients experiencing AESI
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of patients experiencing ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of patients experiencing SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of patients experiencing Serious ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with implantation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of patients with implantation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of time mean arterial pressure (MAP) is in the target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Horizontal adduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Internal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: SABR toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of vaccines meeting release criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of investigational treatment related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in physical performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Consistency of circulating tumor DNA with CT scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Anatomical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentrations of Zuranolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Toxicity score
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnosis score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed 25-Foot Walk (T25-FW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait Speed Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental alertness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Occurrence of ischaemia of the hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Ideas of persecution
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in urinary lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in blood lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Base deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of unrecovered falls
Endpoint domain: Adverse events/effects
Primary endpoint: Total Number of Deaths
Endpoint domain: Mortality/survival
Primary endpoint: Change in Ventilator-associated Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Median Duration of Mechanical Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate Measurement after Local Anaesthetic Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood pressure measurement after local anesthetic administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The FLACC scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Percentage of patients able to receive blinatumomab infusion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bleeding events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in obstructive sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in frequency of drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in quantity of drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in composition of the intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Positive pressure ventilation effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants with Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Concentration (Cmax) of LY4065967
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of LY4065967
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom From Primary Safety Events
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom From Treatment Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy on referral rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 2 mile treadmill time trial performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six minutes walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: World Health Organization's Quality of Life questionnaire (WHOQOL BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Absolute change in Clinical Dementia Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in mean energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assessment of interleukin -6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Assessment of Vascular endothelial growth factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Clinically significant improvements in erectile function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Rate of bladder tumour recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Complete Observation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Sleep difficulties
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Emotional distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Perceived cognitive difficulties
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in 24-hours urine albumin-to-creatinine ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain valence (unpleasantness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of ocular pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Severe Oral Mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total gestational weight gain by the third trimester
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative changes from baseline in ALP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Power in the gamma band in the valence circuit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Negative and positive valence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Biochemical Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants With Disease Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Common Terminology Criteria for Adverse Events (CTCAE) Grade 3 Toxic Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Common Terminology Criteria for Adverse Events (CTCAE) Grade 4 and 5 Toxic Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of inflammation markers in blood and stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Flow Index 6hs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF protein composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cytological analysis of the CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge acquisition about perinatal grief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Support skills acquisition and self-awareness improvement regarding perinatal grief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of satisfaction with simulation learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Penetration-aspiration scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified water swallowing test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to pericarditis recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary change in sleep disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Identification of Neuroblastoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Remission of Ulcerative Colitis (UC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription Opioid Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Two-year biochemical progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Radiological findings in children with clinical suspicion of HIE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of early postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate difference of anagen hairs at 180 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of interventions to reach diagnostic liver biopsy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biochemical Blood Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in LDL-C relative to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of HCV infected participants initiating treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) After a Single Dose of Mavorixafor
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Absolute Neutrophil Count (ANC) to 8 hours Post-dose On Day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Efficacy of Clonidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Report of Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency Scale for the Symptoms of GERD (FSSG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of dairy consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Frequency of nutritious food consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Halitosis Associated Life-quality Test (HALT) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Subject perceived skin health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Outcomes of Holmium Laser Enucleation of the Prostate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Feasibility of delivering CAB-RPV LA
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of delivering CAB-RPV LA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Emergency department visits or hospital readmissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Echographic cardiomyopathy assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient discomfort/pain after ureteroscopy and ureteral stent placement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient ureteral stent symptoms after ureteroscopy and ureteral stent placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in weekly average of worst abdominal pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Weekly increase of ≥1 CSBM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of participants who discontinued study treatment due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative pancreatic fistula incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Time to onset of ventilation after tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological overall response (pOR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Potentially treatment-related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-related complications leading to surgery delays
Endpoint domain: Adverse events/effects
Primary endpoint: Composite rate of clinical complete response or major pathological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Acceptability of Intervention (AIM) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Feasibility of Intervention (FIM) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Classification of asymptomatic/symptomatic respiratory viral infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Freezing severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain subscale of the Western Ontario and McMaster Universities Osteoarthritis criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stiffness subscale of the Western Ontario and McMaster Universities Osteoarthritis criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical function subscale of the Western Ontario and McMaster Universities Osteoarthritis criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systolic blood pressure (SBP) during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient's perception of aesthetics by PAPS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient's perception of aesthetics by Numeri rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient's perception of aesthetics by Global transition scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: All bleeding and vascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in procedural pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coagulation disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Whole-body protein and amino acid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Hamstring-to-quadriceps ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bulbar redness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Child Behavior Checklist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in forgiveness in adult (teachers)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in forgiveness in child (students)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anger in adult (teachers)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anger in child (students)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anxiety in adult (teachers)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anxiety in child (students)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cell-free DNA (cfDNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression-Severity of Illness scale (CGI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and Negative Syndrome Scale (PANSS-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total drug exposure (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in speech reception threshold in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in word recognition score in quiet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants who preferred Osia 3 over Osia 2 sound processor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Analogue Scale/Score (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: digital pain grading method (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuropathic pain assessment scale (DN4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep quality (Pittsburgh sleep quality index, Ascens insomnia scale)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: A-P renal pelvis diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes